256 filings
Page 4 of 13
8-K
91inf9lcbujndhrq
8 Nov 21
Matinas BioPharma Reports Third Quarter 2021 Financial Results and Operational Highlights
6:35am
8-K
l4qs3s
1 Nov 21
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
2z45 dyzdrt
20 Sep 21
Matinas BioPharma Announces Accomplished Biotechnology Executive and Drug Developer Kathryn Penkus Corzo as Nominee to the Board of Directors
7:05am
8-K
xn7 69k0fxw
13 Sep 21
Regulation FD Disclosure
6:05am
8-K
35ii1yoy23 4xcjs
10 Aug 21
Matinas BioPharma Reports Second Quarter 2021 Financial Results and Operational Highlights
6:35am
8-K
xyotv
10 May 21
Matinas BioPharma Reports First Quarter 2021 Financial Results and Operational Highlights
6:35am
8-K
vs2wpux9acfx
29 Mar 21
Matinas BioPharma Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
6:35am
S-8
zi9gjaf3jwi6xaxm
26 Feb 21
Registration of securities for employees
5:26pm
8-K
cfw7 q6wex8lr
1 Feb 21
Regulation FD Disclosure
6:03am
8-K
3a5yuollubk7ozy
27 Jan 21
Submission of Matters to a Vote of Security Holders
5:28pm
8-K
hdu3z
14 Jan 21
Regulation FD Disclosure
7:00am
8-K
j1l7eol333nc73
28 Dec 20
Other Events
6:07am
8-K
3bez 2s1mq2qs
8 Dec 20
Regulation FD Disclosure
12:00am
8-K
k80ujv229ehdgau swi0
1 Dec 20
Matinas BioPharma Appoints Hui Liu, Ph.D., M.B.A. as Chief Technology Officer
5:05pm